Multiple Myeloma
The International Myeloma Foundation launched Myeloma Action Month to raise awareness and take action for myeloma, emphasizing the power of personal stories and experiences to foster global awareness. Multiple myeloma is a type of cancer that begins in the plasma cells, which are an important part of the immune system responsible for producing antibodies to fight infections. It most commonly affects the bone marrow, leading to a variety of symptoms including infections, bone pain and fractures, kidney problems, and anemia. Risk factors include being male, Black, having a family history of the disease, obesity, and having certain precursor conditions like MGUS. Diagnosis involves a comprehensive evaluation through physical exams, blood and urine tests, imaging, and bone marrow biopsies. Treatment strategies are determined based on factors such as the suitability for bone marrow transplant, age, and overall health, and can include targeted therapy, immunotherapy, corticosteroids, chemotherapy, and managing complications. Research and support for multiple myeloma are ongoing, with a focus on understanding and treating the condition more effectively
